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ABSTRACT 
Reck is a membrane-anchored glycoprotein initially identified as a 
transformation suppressor.  Accumulating evidence indicates that 
Reck negatively regulates a wide spectrum of matrix 
metalloproteinases and is commonly down-regulated in malignant solid 
tumors.  Physiological cues that regulate RECK expression, however, 
remained unknown.  In this study, we found that RECK expression in 
mouse embryo fibroblasts increased at high cell density, after 
serum-deprivation, and in the cells treated with two kinase inhibitors, 
PP2 (Src inhibitor) and LY294002 (PI3-kinase inhibitor).  Curve 
fitting indicated that the level of Reck protein as well as its mRNA 
could be approximated by a quadratic function of cell density.  Other 
stimuli, including serum-deprivation, extracellular matrix components 
(type I collagen and fibronectin), the kinase inhibitors, and their 
oncogenic targets (v-Src and PIK3CA E545K), modify the shape of this 
quadratic curve.  Comparison of these modifications suggest that Src 
is involved in the Reck down-regulation under sparse conditions while 
PI3-kinase is involved in the serum-induced Reck down-regulation.  
Fibronectin and type I collagen may counteract with the sparsity-Src 
signaling and the serum-PI3-kinase signaling, respectively.  These 
findings provide a framework for further studies to clarity the 
molecular mechanisms of Reck gene regulation and to find effective 




   Mammalian cells rely on both genetic program and environmental cues in deciding 
their fates and behaviors.  In mouse embryo fibroblasts (MEFs), for instance, lifespan 
is pre-determined by genetic program (senescence), and yet, even in their early passages, 
the cells stop dividing when they lack enough growth factors, anchorage, or space.  
Cancer cells are often less sensitive to these environmental restrictions.     
   Important external stimuli influencing cell fate-decision include humoral factors, 
extracellular matrix (ECM), and adjacent cells. A large body of knowledge has been 
accumulated on the mechanisms of signal transduction through membrane-associated 
receptors for various humoral factors and ECM components.  For instance, receptor 
tyrosine kinases transmit signals of various growth factors by activating multiple 
signaling cascades [1, 2], including Ras/Erk and phosphatidyl inositol 3-kinase 
(PI3K)-Akt pathways [3, 4].  Integrins, a major family of ECM receptors, transmit 
signals through two non-receptor type tyrosine kinases, Fak and Src, to activate several 
down-stream signaling pathways, including Cas/Jnk, Ras/Erk, and Rho/Rac/Cdc42 
pathways [5].  Hence, we now begin to understand how the growth factor cues and the 
ECM cues are integrated to provoke proper cell responses in normal cells, and how 
these mechanisms are deficient in cancer cells.  In contrast, the mechanisms by which 
the cells sense space and avoid one another are still unclear, despite their obvious 
importance in understanding various biological events, such as animal development, 
wound-healing, and carcinogenesis.   
   As an approach to understand how oncogenes induce transformation, a breakdown 
of the contact-inhibited growth regulation, we previously screened genes inducing flat 
reversion (i.e., restored contact-inhibition) in v-K-ras-transformed NIH3T3 cells [6].  
One such gene, RECK, was found to encode a unique membrane-anchored inhibitor of 
matrix metalloproteinases (MMPs) [7].  The level of RECK expression is low in 
fibroblasts after transformation by various oncogenes and in a number of cell lines 
derived from various cancer tissues [8].  Moreover, forced expression of RECK in 
cancer cells resulted in suppression of tumor angiogenesis, invasion, and metastasis in 
animal xenograft models [9].  Subsequent studies with clinical samples not only 
confirmed frequent down-regulation of RECK in a wide variety of solid tumors but also 
revealed significant correlation between the level of residual RECK expression in 
tumors and better prognosis [10].   
   The strong conservation of Reck from fruit fly to man as a single gene seems to 
suggest its pivotal physiological functions.  In fact, Reck-deficient mice die around 
embryonic day 10.5 with reduced tissue integrity and defects in various tissues 
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including blood vessels and the neural tubes [9, 11], suggesting its essential role in 
animal development.  Possible involvements of Reck in the development of skeletal 
muscles, cartilage, and the neuromuscular junctions have also been suggested [12-14].  
At the single cell level, RECK is required for stable adhesion, persistent migration, and 
endocytic inactivation of membrane-bound proteases [15].  Hence, knowledge on the 
physiological stimuli that regulate RECK expression are of great importance in 
understanding a wide range of biological events including cancer progression, 
mammalian development, and cell migration.  Such knowledge may also be useful in 
developing the methods to re-activate RECK expression in cancer cells and suppress 
malignancy. 
   In the present study, we examined the effects of cell density, serum, ECM, several 
inhibitors, and some of their targets on Reck expression in mouse embryo fibroblasts.  
Quantitative analysis of these data revealed potential relationships among these external 
stimuli and signaling molecules in the density-dependent regulation of Reck expression.      
 
2. Materials and methods 
2.1. Cell culture 
   NIH3T3 and v-Src NIH (2-1/NP; a gift from Steve Anderson, University of 
Colorado Health Science Center) were maintained in Dulbecco’s modified Eagle 
medium (DMEM) supplemented with 10% fetal bovine serum and antibiotics (referred 
to as “growth medium” in this paper).  MEF and M2- MEF were established as 
described elsewhere [16] and maintained in αMEM supplemented with 10% FBS and 
antibiotics. NIH3T3 cells were transfected with mammalian expression vector 
pcDNA6-PIK3CA E545K (a gifts from Masahiro Aoki, Kyoto university Graduate 
School of Medicine) and selected in medium containing 8 µg/ml blastcitidine-S to 
establish PIKm NIH.  To determine growth curves, NIH3T3 or MEF cells were plated 
onto thirty 35 mm-dishes at 5x104 cells per dish.  Two dishes were used for cell 
counting, one dish for protein analysis, and the other dishes were refed with fresh 
medium every day.  To arrest cell cycle, NIH3T3 cells were plated at 1x105 cells per 
60-mm dish with growth medium.  After overnight incubation, the cells were exposed 
to serum-free DMEM for 24 h or to the growth medium containing hydroxyurea 
(10mM) or nocodazole (100ng/ml) for 16 h.  For double thymidine-block, the cells 
plated on the previous day were incubated for 16 h in DMEM containing 2 mM 
thymidine, for 8 h in growth medium, followed by the second 16 h incubation in 
DMEM containing 2 mM thymidine.  Dishes coated with type I collagen were 




   PP2, LY294002, PD98059, GF109203x, Y27632, and Toxin B were obtained from 
Calbiochem; hydroxyurea, nocodazole, thymidine, 5-azacitidine, and Trichostatin A 
were from Sigma. 
 
2.3. Immunoblot assay 
   To extract proteins, culture cells were lysed in 50mM Tris-HCl (pH6.8), 1% SDS, 
1mM EDTA, and the protease inhibitor cocktail (Nakarai Tesque).  Proeins were 
separated by SDS-PAGE (8% acrylamide), followed by immunoblot detection using 
monoclonal antibody against RECK (5B11D12) and re-probing with anti-α-tubulin 
(Calbiochem) or anti-Gapdh (Ambion). Immobilon Western (Millipore) was used for 
visualization.  Densitometry was performed using ImageJ64 software. 
 
2.4. Quantitative real-time PCR 
   Total RNA was extracted using Nucleo Spin RNA II (MACHEREY-NAGEL).  The 
amount of mRNAs was measured using SuperScript III Platinum One-Step Quantitative 
RT-PCR System (Invitrogen) or SuperScript III Platinum SYBR Green One-Step 
qRT-PCR Kit (Invitrogen) on Mx 3005P Real-Time PCR System /Mx Pro software 
(Stratagene). Primer pairs and probes for mouse Reck: 
5’-AGGTCTCCAGCAGTCTCC-3’, 5’-GCAGTTCCTTCCAGTTGTG-3’, and 
5’(FAM)-CGCGATCCCACTCCCTGCTCCTCCTCCTCAGATCGCG-(Eclipse)3’ 
(Molecular beacon probe).  Primer pairs for the control mouse hypoxanthine 
phosphoribosyl-transferase 1 (Hprt 1): 5’-AGCGTTTCTGAGCCATTGC-3’ and 
5’-GCGGTCTGAGGAGGAAGC-3’.  Reaction conditions: initial reactions at 50˚C 
for 5 min and at 95˚C for 5 min followed by 45 cycles of reactions at 94˚C for 5 min, at 
55˚C for 40 s, and at 72˚C for 15 s. 
 
2.5. Data analyses 
   The values obtained by densitometry (protein) or qRT-PCR (mRNA) were first 
divided by the values of internal standard (normalized data) and then divided by the 
normalized data for NIH3T3 cells plated at 5x105 cells per 35-mm dish and incubated in 
medium containing 10% FBS (termed “reference sample”).  The obtained value was 
termed “relative Reck level” or (r).  The r values were plotted against cell density (d 
[x106 cells per 35-mm dish]) using Excel 2008 software, and approximation curves with 
highest R2 values were searched among the standard options.  Second order 
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polynomial approximation was the best choice in all cases tested.  The coefficients (p, 
q) of the standard form [y=a(x-p)2+q] of the r-d approximation equation (y=ax2+bx+c) 
were calculated using the following formula: p=-b/2a, q=(4ac-b2)/4a.     
 
3. Results 
3.1. Reck is up-regulated at high cell density in fibroblasts  
   In our previous studies using various cells in culture, we noticed that the expression 
of endogenous RECK can fluctuate to a large extent.  For instance, when a commonly 
used mouse embryo fibroblast line, NIH3T3, was cultured for 10 days starting from 
sparse conditions, the level of Reck protein increased dramatically as time passed and 
the cells proliferated (Fig. 1A, black diamond, and Fig. 1B).  Similar up-regulation of 
Reck protein was found in a newly established mouse embryo fibroblast line (MEF) 
derived from a wild type mouse embryo (Fig. 1A, white diamond, and Fig. 1C).  MEF 
resembles primary fibroblasts in its low clonogenicity, very low transfection efficiency, 
and higher persistence during long term culture.  To clarify whether the Reck 
up-regulation depends on cell density or some other factors associated with prolonged 
incubation, we plated NIH3T3 or MEF at several different cell densities and incubated 
for 48 h.  The data clearly demonstrated density-dependent up-regulation of Reck both 
in NIH3T3 (Fig. 1D, black bars) and MEF (Fig. 1D, white bar).  We also examined the 
regulation of Reck expression in another fibroblast line, M2- MEF, derived from a 
mouse embryo lacking one of the Reck targets, Mmp-2 (Fig. 1D, striped bars).  
Although this cell line also show density-dependent Reck regulation, the level of Reck 
was significantly higher as compared to that in MEF or NIH3T3.  Measurement of 
Reck mRNA by quantitative reverse transcription-polymerase chain reaction 
(q-RT-PCR) revealed that the density-dependent up-regulation of Reck in these cell 
lines was seen at the mRNA level (Fig. 1E), although the proportion of Reck protein 
(Fig. 1D) and Reck mRNA (Fig. 1E) seems different among cell lines, suggesting 
different degree of post-transcriptional regulation among the cell lines.   
 
3.2. Reck is up-regulated after serum-deprivation in fibroblasts 
   We noticed that the concentration of fetal bovine serum (“serum”) in culture 
medium also affected Reck expression.  When NIH3T3 cells plated at the same cell 
density were incubated in medium containing various concentrations of serum for 24 h, 
clear inverse correlation between serum concentration and Reck protein level was 
observed (Fig. 2A).  This regulation seems to also operate at the mRNA level (Fig. 2B).  
Time course studies suggested that this up-regulation took place rather slowly: Reck 
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level continued to build up over 24 h (Fig. 2C).  Decline of Reck level after 24 h 
serum-deprivation also continued at least for 24 h (Fig. 2D).   
 
3.3 Effects of various inhibitors on Reck expression 
   Since high cell density and serum-deprivation both lead to cell cycle arrest, we 
suspected that Reck expression might be commonly activated when cell cycle was 
arrested.  To test this possibility, we monitored the level of Reck protein in NIH3T3 
cells after double thymidine-block (Td; cell cycle arrest at G1/S boundary), treatment 
with hydroxyurea (HU; cell cycle arrest in S phase), or with nocodazole (Nz; cell cycle 
arrest in G2/M).  These treatments, however, showed little effects on Reck expression 
(Fig. 3A), supporting the idea that specific environmental cues (e.g., high cell density 
and serum-deprivation), rather than cell cycle-arrest, are responsible for Reck 
up-regulation.   
   Previous studies indicated that RECK expression in certain transformed or 
cancer-derived cells could be induced by treatment with a DNA methyltransferase 
inhibitor, 5-azacytidine (AzC), or histone deacetylase inhibitor, trichostatin A (TSA) 
[17-20] .  To test whether DNA methylation and/or histone acetylation play any roles in 
the density- and/or serum-dependent regulation of Reck expression in NIH3T3 cells, we 
treated the cells at low cell density (2x104 per 35 mm-dish) with these inhibitors in the 
presence of 10% serum (Fig. 3B).  Reck expression was induced by TSA but not by 
AzC (Fig. 3B, lanes 1-3), suggesting that histone deacetylation, but not DNA 
methylation, may be involved in the mechanism to keep Reck expression relatively low 
under these conditions (i.e., low density, high serum).  Moreover, the effects of TSA 
were marginal at high cell density (Fig. 3C, lane 4) and can even be suppressive in 
serum-free medium (Fig. 3C, lanes 6, 8), supporting the idea that under such conditions, 
histones are abundantly acetylated, so that the histone deacylase inhibitor (TSA) cannot 
exert strong, positive effects on Reck expression.   
To find clues to the signaling pathways affecting Reck expression, we also 
tested the effects of some selective inhibitors targeting molecules involved in the 
integrin or growth factor signaling.  The inhibitors we used (and their targets) are as 
follows: GF109203x (protein kinase Cα, βI, βII, γ, δ, ε), PP2 (Src), PD98059 (Mek1), 
LY294002 (PI3K), Y27632 (Rock), and ToxinB (Rac, Cdc42).  When NIH3T3 cells at 
low cell density were treated with sub-toxic doses of each drug for 48 h in the presence 
of 10% serum, significant changes in Reck expression could be detected after treatment 
with GF109203x, PP2, or LY294002 (Fig. 3D).  PP2 and LY294002 co-operatively 
up-regulated Reck at low cell density in the presence of 10% serum (Fig. 3E).   
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3.4. Relationship between cell density and serum-deprivation in the regulation of Reck 
expression  
   Having found the strong influence of cell density and serum concentration on Reck 
expression, we attempted to clarify the extent of, and the relationship between, the 
effects of these two factors on Reck.  NIH3T3 cells were plated at a series of different 
cell densities, incubated in medium containing 10% serum or in serum-free medium for 
24 h, and the level of Reck protein was estimated by immunoblot assay (Fig. 4A) 
followed by densitometry.  In this and following experiments, the “relative level of 
Reck (r)” was defined as the level of Reck protein or mRNA normalized against a 
loading control, α-tubulin or Hprt mRNA, and then divided by the data for a reference 
sample [i.e., NIH3T3 cells at plating density (d) of 5x105 per 35mm-dish in 10% serum].  
When we plotted r against d, the data for the cells at both serum concentrations were 
found to fit 2nd order polynomial approximation curves (i.e., parabola) with relatively 
high accuracy (R2 > 0.97) (Fig. 4B).  This means that r can be approximated by a 
quadratic function of d.  The differences in shape and position between the two 
quadratic curves suggest that serum affects multiple coefficients of this function.   
   To assess the feasibility of using such curve-fitting technique in evaluating the 
effects of various treatments on Reck expression, we first analyzed the data from five 
independent control experiments [i.e., measurements of Reck in NIH3T3 cells at a 
series of cell densities in the presence of 10% serum].  The profile of 5 coefficients (“a, 
b, c, p, q” described Fig. 4C) was found to stay reasonably constant (Fig. 4D, black 
bars), supporting the idea that any significant change in the profile after certain 
treatment may be considered meaningful.  The averaged “Reck protein-cell density” 
(or dp-r) relationship for NIH3T3 was as follows: r = -0.547 d2 + 1.874 d + 0.1296 [or r = 
1.735 - 0.547 (d - 1.713)2]. 
 
3.5. Reck regulation in MEFs and after treatment with kinase inhibitors 
   Similar analyses of the data shown in Fig. 1D indicated that the dp-r relationship for 
MEF and M2- MEF also fit quadratic approximation curves, albeit with altered shapes 
(Fig. 4E).  Hence, the quadratic model may be applicable to multiple fibroblastic cell 
lines.  Moreover, both of the curves show vertexes, an important feature of parabola, 
providing additional evidence supporting quadratic model.   
   The protein kinase inhibitors, PP2 and LY294002, seem to have effects distinct from 
each other on the dp-r curve.  The PP2-treated cells gave rise to a flatter curve (Fig. 
5A), while the LY294002-treated cells causes left-ward shift of the curves (Fig. 5B) as 
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compared to the control data.  Hence, although these chemicals seemed to have similar 
effects on Reck expression when tested at a relatively low cell density (Fig. 3D, E), their 
modes of action probably differ from each other, as we noticed only when their effects 
were tested at a series of different cell densities.   
 
3.6. Effects of ECM components and oncogenes on Reck mRNA expression 
   As we compare the cells on different substrates (e.g., dishes coated with ECM 
components), the contaminating substrate components may hinder accurate protein 
determination required for quantitative immunoblot assay. In transformed cells, elevated 
proteolytic activity makes it difficult to measure the level of Reck protein accurately by 
immunoblot-densitometry.  In such cases, estimation of Reck expression at the mRNA 
level may be more reliable.  Comparison among three independent control experiments 
[i.e., measurements of Reck mRNA by qRT-PCR in NIH3T3 plated at a series of 
different densities in the presence of 10% serum] revealed that the profile of coefficients 
were similar to that for Reck protein and reasonably constant (Fig. 4D, compare white 
bars with black bars).  Thus, comparison of these coefficients at the mRNA level may 
also be useful in assessing the effect of various treatments on Reck expression.  The 
averaged “Reck mRNA-cell density” (or dr-r) relationship in NIH3T3 was as follows: r 
= -0.7675 d2 + 1.817 d + 0.1761 [or r = 1.251 - 0.7675 (d - 1.184)2]. 
   Using this approach, we found an interesting distinction between the effects of type 
I collagen (Coll-1; Fig. 5C) and fibronectin (FN; Fig. 5D) on Reck mRNA expression.  
Coll-1 yielded more closed parabola, whereas FN caused downward shift of the curve.  
Hence, in the lower cell density range, Coll-1 and FN have opposing effects. 
   We also examined the effects of v-Src [a constitutively active form of PP2 target] 
and PIK3CA E545K (PIKm) [an oncogenic form of a subunit of LY294002 target] to 
see whether these genes show effects opposite to PP2 and LY294002, respectively.  
The effects of v-Src were striking: almost complete loss of density-dependent Reck 
up-regulation (Fig. 5E).  The effects of PIKm were milder: more open parabola with 
slightly lower vertex and rightward shift (Fig. 5F).        
 
4. Discussion 
   What can we learn from these data?  For quantitative comparison, four coefficients 
(a, c, p, q) of the d-r curves at the protein level (Fig. 6A) and the mRNA level (Fig. 6B) 
are summarized.  We chose these coefficients, since they directly determine the basic 
features of parabola: a) its shape or closeness, c) y-intercept, p) axis of symmetry, and q) 
height of vertex.  We adopted –a (or |a|) to make the values positive and to make it 
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possible to compare all coefficients in one graph.  To facilitate comparison among the 
coefficients, the values relative to those for the control group [i.e., NIH3T3 in 10% 
serum] are presented.  The trends found in these graphs are summarized in Fig. 6C. 
   At first sight, it seems evident that the value c is relatively high in most of the cases 
where we found Reck up-regulation.  This, however, is likely to be a consequence of, 
rather than a clue to, the mechanism by which Reck expression is modulated, since we 
focus on the treatments effective in up-regulating Reck expression in a low-cell-density 
range (i.e., d close to zero) in this study.   
   Upon close inspection of these coefficients (Fig. 6A-C) and the d-r curves (Fig. 4 5), 
however, we noticed that there were at least three ways to up-regulate Reck expression 
at low cell density (Fig. 6D): (1) to make parabola more open by lowering |a| [PP2], (2) 
to close parabola by increasing |a| plus lowering p [0% serum, MEF, M2- MEF, 
LY294002, and Coll-1], and (3) to shift the curve upward by increasing q [0% serum, 
M2- MEF, and Coll-1].  FN may also belong to the class 1, although the 
right-downward shift of vertex (higher p and lower q) (Fig. 6B, C) places this curve 
slightly below the control curve (Fig. 5D).  Of note, all the elements of the class 3 
turned out to be also the elements of class 2, suggesting that the class 3 can be a 
subgroup of the class 2.   
   We also noticed that there are at least two ways to down-regulate Reck at high cell 
density: (4) to make Reck expression insensitive to cell density [v-Src] (Fig. 5E), and 
(5) to make the curve more open by increasing the coefficient p [PIKm] (Fig. 5F; Fig. 
6B, C).   
   These findings can be explained, if we interpret the data as follows (Fig. 6E): i) 
Reck is down-regulated when the cells are sparse, ii) Src is involved in such 
sparsity-dependent Reck down-regulation, iii) serum makes the cells (and/or the Reck 
gene) less sensitive to cell density and also decreases rmax, iv) PI3K is involved in these 
effects of serum, v) Coll-1 counteracts with serum, and vi) FN counteracts with Src (Fig. 
6E).  This model predicts that the constitutively active v-Src suppresses Reck 
expression at any cell density (see Fig. 5E), while PP2 (a Src inhibitor) suppresses Reck 
down-regulation at low cell density (see Fig. 5A and Fig. 6D (1)).  The model also 
predicts that serum-deprivation, LY294002 (a PIK inhibitor), and Coll-1 up-regulate 
Reck at lower cell density (see Figs. 4B, 5B, 5C) while the constitutively active PIK 
makes the cells (and/or the Reck gene) less sensitive to cell density, i.e., lower Reck 
expression even at high cell density (Fig. 5F).  This model is largely consistent with 
our findings and may serve as a working hypothesis useful for designing further 
experiments to delineate the molecular mechanism of Reck gene regulation and to find 
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effective Reck expression modulators.   
   This study has also revealed that the r-d curves for M2- MEF are remarkably similar 
to those for NIH3T3 on Coll-1-coated dishes (Fig. 6A-C).  Since MMP-2 can digest 
Coll-1 [21] and Reck inhibits MMP-2 [9, 22], the Reck over-expression found in these 
MMP-2-deficient cells may largely be explained by accumulation of Coll-1 or some 
other molecules having similar effects on Reck.   
   Although the molecular basis of density-sensing in this system is presently unclear, 
involvement of the ECM-integrin signaling seems to be a good candidate.  The above 
model (Fig. 6E) predicts that Src activity is suppressed when cell density goes up.  Our 
finding that PP2 and FN share similar effects on the r-d curve is interesting in this 
respect; accumulation of FN at higher cell density may contribute to the Src-suppression.  
Similarity between serum-deprivation and Coll-1, on the other hand, may suggest a role 
for Coll-1 in the regulation of sensitivity to, rather than the sensing itself of, cell density.   
   FAK is a major signaling molecule of the integrin-based focal adhesion complexes 
and an important substrate and binding-partner for Src [1, 5, 23, 24].  It also binds, 
upon tyrosine-phosphorylation, with the SH2-domain of p85, the regulatory subunit of 
PI3K [25].  We initially suspected that FAK might be a common target which integrates 
the Src-mediated sparsity-signaling and the PI3K-mediated growth factor-signaling.  
We found, however, that a specific FAK inhibitor (PF573228) [26] had little effects on 
Reck expression (M. Hatta, unpublished).  This, together with other findings presented 
in this report, suggest that Src and PI3K may impinge on Reck through separate 
pathways.  Our data (Fig. 3C) also suggest that the actions of both pathways on Reck 
gene probably involve modulation of histone acetylation.  Earlier studies indicated that 
the Ras/Erk pathway suppressed Reck expression and the Sp1 site down-stream of the 
transcriptional start site was probably involved in this suppression [17, 27, 28].  It is 
therefore unexpected that the effects Mek1 (Ras/Erk pathway) inhibitor (PD98059) on 
Reck expression was marginal and that the PI3K pathway seems to be more prevalent in 
this system.  Elucidation of the cis-elements involved in Reck repression mediated by 
PIK, Src, and their inhibitors Src may provide more clues to the relationship between 
these two pathways.    
   In this study, we focused on density-dependent regulation of Reck expression.  The 
method used in this study to analyze the effects of various treatments may be useful in 
evaluating various other agents, such as chemicals and oncogenes, on Reck expression 
as well as on the expression of other density-dependent genes.  It remains to be tested 
whether we can illuminate other aspects of Reck regulation by analyzing the effects of 
various treatments on Reck expression as a function of serum concentration (see Fig. 
 12 
2A).  It is now clear that Reck is under the control of microRNA-mediated 
post-transcriptional regulation [29-31].  Some of our data (e.g., Fig. 1D, E) indicated 
the difference among cell lines in the ratio of Reck protein and mRNA.  Whether 
post-transcriptional regulation, such as differential expression of microRNAs, plays any 
roles in the density-dependent or serum-dependent Reck regulation is another 
interesting issue to be addressed in future studies.  
 
5. Conclusion 
   Reck expression is up-regulated at high cell density and after serum-deprivation at 
both mRNA and protein levels in mouse embryo fibroblasts.  Reck expression at low 
cell density could be up-regulated by PP2, LY294002, and TSA, while Reck expression 
at high cell density was suppressed by v-Src and an oncogenic mutant of PI3K.  Our 
kinetic studies suggested that Src is involved in the Reck down-regulation under sparse 
conditions while PI3K is involved in the Reck down-regulation by serum.  Fibronectin 
and type I collagen may counteract with these two regulatory pathways, respectively.      
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Fig. 1. Cell density-dependent regulation of Reck expression. (A) Growth curves of 
NIH3T3 (black diamond) and MEF (white square).  The cells were plated onto a series 
of 35-mm dishes at 5x104 cells per dish on day 0, and the number of cells in two dishes 
was counted every day after suspension by trypsin-treatment.  Medium of remaining 
dishes was refreshed every day. (B) Reck expression in NIH3T3 detected by 
immunoblot assay. The cells were harvested at indicated time point, and the level of 
Reck protein (upper panel) was assessed by immunoblot assay and densitometry.  The 
data were normalized against α-tubulin (second panel), divided by the value of day 2, 
and shown in bar graph (bottom panel). (C) Reck expression in MEF detected by 
immunoblot assay.  Experiments similar to those described in panel B were performed 
using MEF cells. (D) The level of Reck protein in NIH3T3 (black bars), MEF (white 
bars), or M2- MEF (striped bars) at various cell densities.  The cells plated at 0.03, 0.1, 
0.3, or 1 [x106 cells per 60-mm dish] were harvested after incubation for 48 h, and the 
level of Reck protein was determined by immunoblot assay and densitometry. The data 
were first normalized against α-tubulin and then divided by the normalized value for the 
NIH3T3 cells at the lowest cell density. (E) The level of Reck mRNA in NIH3T3 (black 
bars), MEF (white bars), or M2- MEF (striped bars) at various cell densities.  The cells 
plated onto 60-mm dishes at indicated densities were harvested after incubation for 48 h, 
and the total RNA was extracted for Reck mRNA measurement by qRT-PCR.  The data 
were first normalized against Hprt and then divided by the normalized value for the 
NIH3T3 cells at the lowest cell density.   
 
Fig. 2. Serum-dependent regulation of Reck expression. (A) The effects of serum 
concentration on the level of Reck expression in NIH3T3.  NIH3T3 cells plated at 
1x105 cells per 35-mm dish on the previous day were treated for 24 h in DMEM 
containing indicated concentration of serum.  The level of Reck protein was estimated 
by immunoblot assay. (B) The effects of serum-deprivation on the level of Reck mRNA.  
NIH3T3 cells plated at 1.5x105 cells per 35-mm dish on the previous day were 
incubated in medium containing 10 % serum or in serum-free medium for 24 hr, and the 
level of Reck mRNA was determined by qRT-PCR. (C) Time course of Reck 
up-regulation after serum withdrawal.  NIH3T3 cells plated at 1.5x105 cells per 60-mm 
dish in growth medium on the previous day were incubated in serum-free DMEM for 
indicated period of time, and the level of Reck protein was assessed by immunoblot 
assay. (D) Time course of Reck down-regulation in serum-starved cells after serum 
addition.  NIH3T3 cells plated at 1x105 cells per 60-mm dish on the previous day were 
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serum-starved for 24 h and refed with growth medium.  After incubation for indicated 
period of time, the cells were harvested for immunoblot assay.   
 
Fig. 3. Effects of various inhibitors on Reck expression.  (A) Effects of cell cycle 
arrest by various treatments on Reck expression.  NIH3T3 cells plated at 1x105 cells 
per 60-mm dish on the previous day were incubated in either serum-free DMEM (sf) or 
in growth serum containing 10mM hydroxyurea (HU) or 100ng/ml nocodazole (Nz) for 
16 or 40 h.  The cells were also arrested by double-thymidine block (Td) using 2mM 
thymidine. Reck expression was estimated by immunoblot assay.  Since these 
treatments may affect the level of a “house keeping gene” used as a loading control, we 
employed two controls, α-tubulin (black bars) and Gapdh (white bars), to confirm the 
results.  (B) Effects of 5-azacitidine (AzC) and Trichostatin A (TSA) on Reck 
expression. NIH3T3 cells plated at 2x104 or 1x105 cells per 35 mm-dish on the previous 
day were treated with 2.5 mM AzC or 100 nM TSA for 48h, and the level of Reck 
protein was estimated by immunoblot assay.  Band intensity (bottom) is the 
densitometric value first normalized against α-tubulin and then divided by normalized 
value for the control sample [i.e., low density, mock-treated cells] (lane 1). (C) Effects 
of TSA and serum on Reck expression. NIH3T3 cells plated at 1x105 or 5x105 cells per 
35-mm dish on the previous day were treated with 100 nM TSA for 24h in the presence 
or absence of serum, and the level of Reck protein was estimated by immunoblot assay.  
Band intensity (bottom) is the densitometric value first normalized against α-tubulin 
and then divided by the normalized value for the cells plated at the lower cell density 
and incubated in growth medium without TSA. (D) Effects of several inhibitors 
targeting signaling molecules on Reck mRNA expression.  NIH3T3 cells plated at 
5x104 cells per 60-mm dish on the previous day were treated with GF109203x (GF; 1.5, 
4.5 µM), PP2 (1.5, 4.5, 9 µM), PD98059 (PD; 1, 5, 10 µM), LY294002 (LY; 1, 5, 10 
µM), Y27632 (Y: 1, 5, 10µM), or Toxin B (TxB; 4, 8 ng/ml) for 48 h.  The level of 
Reck mRNA was determined by qRT-PCR, and the data were first normalized against 
Hprt and then divided by the normalized value for the untreated cells. (E) Co-operative 
effects of PP2 and LY294002 on Reck mRNA expression.  NIH3T3 cells plated at 
2x104 cells per 35-mm dish were treated with 10 µM PP2, 10 µM LY294002 (LY), or 
both for 48 h, and the level of Reck mRNA was determined by qRT-PCR.  . 
 
Fig. 4. Density-dependent expression of Reck protein after serum-deprivation and in 
MEFs. (A) Effects of serum-deprivation on density-dependent Reck expression.  
NIH3T3 cells plated onto 35-mm dish at indicated cell densities with growth medium 
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on the previous day were incubated for additional 24 h in the presence (10%) or absence 
(0%) of serum.  Reck and α-tubulin were detected by immunoblot assay. (B) The Reck 
protein versus cell density (or rp-d) curves for NIH3T3 in the presence (black circles) or 
absence (white squares) of 10% serum.  The Reck band intensity normalized against 
α-tubulin and then divided by the value of the control sample [5x105 cells per dish, 10% 
serum] (y-axis) are plotted against cell density (x-axis).  Curve fitting revealed that the 
best fit for both data sets were 2nd order polynomial equations.  The averaged control 
curve (n=6; see D) is shown in grey dotted line. (C) A quadratic function characterizing 
the relationship between relative Reck level (r) and plating density (d).  Two forms of 
quadratic functions (top) and the property of 5 coefficients (a, c, p, q) are described. (D) 
Variation in 5 coefficients among five control experiments.  The r-d approximation 
curves were obtained from a series control experiments (NIH3T3 in 10% FCS) and 
mean+s.e.m. of each coefficient is presented.  Black bars represent coefficients for 
Reck protein (n=5) and white bars for Reck mRNA (n=3). (E) The rp-d curves for 
NIH3T3 (black circles), MEF (white squares), and M2- MEF (gray triangles).  The 
data shown in Fig. 1D were used to draw approximation curves as described in B.   
 
Figure. 5. Effects of various treatments on the r-d curve.  (A) Effects of PP2 on the 
density-dependent up-regulation of Reck protein in NIH3T3 cells.  The rp-d curves for 
NIH3T3 cells incubated for 48 h in the absence (black circles) or presence of 10 µM 
PP2 (white squares) are shown.  Reference sample: NIH3T3 plated at 5x105 per 
35-mm dish and incubated in the absence of inhibitor. (B) Effects of LY294002 on the 
density-dependent up-regulation of Reck protein in NIH3T3 cells.  The rp-d curves for 
NIH3T3 cells incubated for 48 h in the absence (black circles) or presence of 10 µM 
LY294002 (white squares) are shown.  Reference sample: NIH3T3 plated at 5x105 per 
35-mm dish and incubated in the absence of inhibitor. (C) Effects of type I collagen on 
the density-dependent up-regulation of Reck mRNA in NIH3T3 cells.  The Reck 
mRNA versus cell density (or rr-d) curves for NIH3T3 cells incubated for 48 h on 
regular tissue culture dishes (black circles) or dishes coated with type I collagen (white 
squares) are shown.  Reference sample: NIH3T3 plated at 5x105 per 35-mm regular 
dish. (D) Effects of fibronectin on the density-dependent up-regulation of Reck mRNA 
in NIH3T3 cells.  The rr-d curves for NIH3T3 cells incubated for 48 h on regular tissue 
culture dishes (black circles) or dishes coated with plasma fibronectin (white squares) 
are shown.  Reference sample: NIH3T3 plated at 5x105 per 35-mm regular dish. (E) 
Effects of v-Src on the density-dependent up-regulation of Reck mRNA in NIH3T3 cells.  
The rr-d curves for NIH3T3 (black circles) or v-Src NIH (white squares) incubated for 
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48 h in growth medium are shown.  Reference sample: NIH3T3 plated at 5x105 per 
35-mm dish. (F) Effects of an oncogenic PIKCA mutant (E545K) on the 
density-dependent up-regulation of Reck mRNA in NIH3T3 cells.  The rr-d curves for 
NIH3T3 (black circles) or PIKm NIH (white squares) incubated for 48 h in growth 
medium are shown.  Reference sample: NIH3T3 plated at 5x105 per 35-mm dish. 
 
Fig. 6. Evaluation of approximation curves. (A) Properties of the rp-d curves.  Four 
coefficients (-a, c, p, q) of the approximation curves shown in Figs. 4B, E and Fig. 5A, 
B were divided by the value of the control experiments (NIH3T3 in 10% serum, n=5). 
(B) Comparison between the coefficients of rr-d curves.  Four coefficients of the 
approximation curves shown in Figs. 5C-F were divided by the value of the control 
experiments (NIH3T3 in 10% serum, n=3). (C) Summary of the trends found in panels 
A and B. H, high; HH, very high; L, low; LL, very low.  Parentheses indicate relatively 
small changes. (D) Three modes of Reck up-regulation in a lower cell-density range 
found in this study. (E) A model consistent with our findings. The level of Reck is 
determined by the quadratic function of cell density.  Density dependent up-regulation 
of Reck (in the left half of the curve) is a consequence of the sparsity-dependent 
activation (or density-dependent inactivation) of Src.  Serum, on the other hand, 
decreases the sensitivity of Reck expression to cell density, largely through activation of 
PI3K.  Type I collagen may counteract with serum, while fibronectin may regulate the 
sparsity-dependent effects.   
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